Healthcare & Life Sciences

Sengine Medicine

acquired

About

Sengine Medicine uses AI to perform high throughput drug sensitivity testing on patient-derived cancer organoids to enable personalized cancer treatment selection.

Explore Sengine Medicine's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.